Response to: A Correspondence on Second COVID-19 infection in a patient with granulomatosis with polyangiitis on rituximab'' by Tampe et al

Research output: Contribution to journalLetterpeer-review

Original languageEnglish (US)
JournalAnnals of the rheumatic diseases
StateAccepted/In press - 2021


  • COVID-19
  • Rituximab
  • granulomatosis with polyangiitis
  • vaccination

ASJC Scopus subject areas

  • Rheumatology
  • Immunology and Allergy
  • Immunology
  • Biochemistry, Genetics and Molecular Biology(all)

Cite this